New Key Statistics Module, Z-Score and F-Score
OSL:CRNA Key Ratios
| Market Cap kr M | 25.38 |
| Enterprise Value kr M | 115.22 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 1.93 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) kr M | 10.00 |
| EPS (TTM) kr | -59.42 |
| Beneish M-Score | -7.03 |
| 10-y EBITDA Growth Rate % | 15.60 |
| 5-y EBITDA Growth Rate % | 46.10 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.26 |
| EV-to-EBITDA | -2.83 |
| PEG | -- |
| Shares Outstanding M | 8.29 |
| Net Margin (%) | -3,732.22 |
| Operating Margin % | -4,337.20 |
| Pre-tax Margin (%) | -4,356.20 |
| Quick Ratio | 0.23 |
| Current Ratio | 0.23 |
| ROA % (ttm) | -627.44 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -517.57 |
| Dividend Yield % | -- |
| Altman Z-Score | -61.34 |
OSL:CRNA Number of Guru Trades
OSL:CRNA Volume of Guru Trades
Gurus Latest Trades with OSL:CRNA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OSL:CRNA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers